Early Detection, Better Protection: Nu.Q Aims to Save Dog’s Lives With Accessible Cancer Screening
Description
In this heartfelt episode of Petworking, host Peter Kenseth interviews Dr. Tom Butera, CEO of Volition Veterinary, about their groundbreaking Nu.Q Cancer screening technology. Peter shares his personal experience with his dog Peony's melanoma diagnosis and how early detection saved her life.
Dr. Butera, with his impressive background spanning academia, clinical practice, and corporate veterinary medicine, explains how Nu.Q is transforming early cancer detection in pets. This simple blood test can identify cancer biomarkers before symptoms appear, potentially saving millions of canine lives.
With approximately 6 million dogs diagnosed with cancer annually in the US alone, this technology represents a paradigm shift in veterinary medicine - moving from treating symptomatic animals to early detection when immune systems are still strong.
Learn about:
- How the Nu.Q test works and which cancers it detects best
- When your dog should be screened (hint: all senior dogs, and predisposed breeds much earlier)
- The potential revolution in cancer treatment protocols
- How early detection can dramatically improve survival rates and quality of life
This episode offers invaluable information for every dog parent who wants to maximize their time with their beloved companion. Don't miss this important conversation about protecting your pet through early cancer detection!
United States
